Non-prescription and compounded peptides such as BPC-157, CJC-1295/Ipamorelin, AOD-9604, and MOTS-c are not FDA-approved for weight loss and lack the same regulatory oversight and clinical safety data as the GLP-1 drugs in the table above, which is why they should only be used under the guidance of a licensed medical provider who can order lab work, personalize dosing, and monitor for side effects throughout treatment
This dual-pathway approach represents the cutting edge of peptide-based weight loss research and has already demonstrated clinical significance in human studies
We monitor every Liraglutide patient with regular check-ins, dose adjustments, and lab work as needed
5 and 6)
Instead, focus on healthy foods high in fiber and protein, such as whole grains, vegetables, fruits, legumes, and quality protein sources like fish, chicken breast, and tofu
Through this process, he acquired a deeper understanding of health and wellness, which he now offers his patients in Tampa and elsewhere.